TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates 
TORONTO, April 06, 2017 -- Penfund, an independent provider of junior capital to middle market companies located in the United States and Canada, announced today the completion of a U.S. $75 million 2nd lien debt investment in Aveanna Healthcare (“Aveanna”). Aveanna was formed through the merger of Epic Health Services (“Epic”) and PSA Healthcare (“PSA”) and is owned by Bain Capital Private Equity, J.H. Whitney Capital Partners, management and other investors including Penfund.
Headquartered in Atlanta, Georgia, Aveanna is the largest pediatric home healthcare company in the United States, providing essential nursing services to medically fragile children in 23 states. The company is led by a seasoned management team including Rod Windley as Executive Chairman, Tony Strange as CEO, and Jeff Shaner as COO who were formerly executives with PSA and Gentiva Health Services.
“We are pleased to support Aveanna Healthcare as it joins two best-in-class operators in Epic and PSA,” stated Nicole Fich, a partner at Penfund. “Penfund has previously had the pleasure of partnering with PSA on multiple occasions and we believe the merger will allow Aveanna to deliver high quality, comprehensive care to pediatric patients and provide critical support to their families.”
Adam Breslin, a partner at Penfund, added “We are delighted to invest in Aveanna. With its scale and focus on pediatric home nursing, we believe Aveanna is uniquely positioned to be a dependable and valued partner to patients, hospitals, referral sources and payors.”
About Aveanna Healthcare
Based in Atlanta, Ga., Aveanna Healthcare is the nation's largest and preeminent provider of pediatric home care. Aveanna has 180 locations in 23 states, with 26,000 caregivers currently serving over 40,000 patients. A privately-owned company, Aveanna is dedicated to providing outstanding care with compassion, quality and clinical excellence.
Website: www.aveannahealthcare.com
About Penfund
Penfund is a leading provider of junior capital to middle market companies throughout North America. The firm is owned by its management team and is currently investing its most recently established fund, Penfund Capital Fund V, which has $724 million of committed capital. Penfund manages funds sourced from pension funds, insurance companies, banks, family offices and high-net-worth individuals and has invested more than $3 billion in over 225 companies since its establishment in 1979. Assets and capital under management currently exceed $1.2 billion.
Website: www.penfund.com
For further information, please contact: Penfund Nicole Fich Partner (416) 645-3791 [email protected] Penfund Adam Breslin Partner (416) 645-3796 [email protected]
